Polypid Ltd Net Income per Employee (PYPD), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Polypid Ltd  (NASDAQ: PYPD)
 

Polypid Ltd Net Income per Employee

PYPD's Quarterly Results, Trends, Rankings, Statistics
Polypid Ltd's Income per employee fell in the second quarter 2025 on a trailing twelve month basis to $ 216,119, but the productivity of Polypid Ltd's 59 employees remained above the company average.
The Healthcare sector has seen employees of 5 other companies achieving higher income per employee. While Polypid Ltd's total ranking has deteriorated compared to the previous quarter from to 372.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PYPD Net Income per Employee (Jun 30 2025)
II. Quarter		 (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Net Income Change - 397.21 % - - -
Net Income per Employee (TTM) $ 216,119 385,220 -7,746 662,712 769,390
PYPD's Total Ranking # 372 # # # # 407
Seq. Net Income Change - - - - -

PYPD Company Profile >> Back to PYPD Efficiency Comparisons >> Compare PYPD Net Income per Employee to its Competitors

PYPD Net Income per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 6
Healthcare Sector # 33
Overall Market # 372

Net Income per Employee Statistics
High Average Low
$ 491,898 $ -214,369 $ -722,051
(Dec 31 2024)   (Dec 31 2021)







Companies with similar Income per Employee for 12 month ending Jun 30 2025, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2025Number of Employees Jun 30 2025
Gilead Sciences Inc   371,235.29 $ 6,311.000  Million 17,000 
Adma Biologics Inc   322,918.08 $ 208.928  Million 647 
Stoke Therapeutics Inc   308,729.41 $ 52.484  Million 170 
Incyte Corporation  306,213.08 $ 870.870  Million 2,844 
Regeneron Pharmaceuticals Inc   289,331.60 $ 4,458.600  Million 15,410 
Acadia Pharmaceuticals Inc   278,395.99 $ 222.160  Million 798 
Eli Lilly And Company  275,998.00 $ 13,799.900  Million 50,000 
Puma Biotechnology Inc   270,675.98 $ 48.451  Million 179 
Dariohealth Corp   267,751.52 $ 44.179  Million 165 
Entera Bio Ltd   267,545.45 $ 5.886  Million 22 
Cytodyn inc   267,500.00 $ 3.745  Million 14 
Edwards Lifesciences Corporation  258,850.00 $ 4,141.600  Million 16,000 
Abeona Therapeutics Inc   253,283.19 $ 57.242  Million 226 
Arcutis Biotherapeutics Inc   249,084.75 $ 88.176  Million 354 
Innoviva Inc   243,075.47 $ 38.649  Million 159 
Keros Therapeutics Inc   240,679.49 $ 18.773  Million 78 
Lantheus Holdings Inc   227,160.94 $ 271.003  Million 1,193 
Semnur Pharmaceuticals Inc   219,222.79 $ 8.330  Million 38 
Merck and Co Inc   218,906.67 $ 16,418.000  Million 75,000 
Biogen Inc   204,066.67 $ 1,530.500  Million 7,500 
Biomarin Pharmaceutical Inc  204,048.74 $ 657.241  Million 3,221 
Corcept Therapeutics Inc  180,819.18 $ 131.998  Million 730 
Zoetis Inc   179,379.31 $ 2,601.000  Million 14,500 
Neurocrine Biosciences Inc   174,150.00 $ 348.300  Million 2,000 
Alkermes Plc   169,973.66 $ 348.446  Million 2,050 
Monte Rosa Therapeutics Inc   161,120.00 $ 24.168  Million 150 
Johnson and Johnson  160,944.60 $ 22,661.000  Million 140,800 
Bristol myers Squibb Company  155,876.92 $ 5,066.000  Million 32,500 
Emergent Biosolutions Inc   155,000.00 $ 139.500  Million 900 
Intuitive Surgical Inc   154,309.38 $ 2,626.500  Million 17,021 


Date modified: 2026-07-07T12:42:51+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.